Who owns TVTY - TIVITY HEALTH INC - COM based on 13F filings?

Open this security page to review the newest available 13F ownership history, top reported holders, and period-by-period changes.

TIVITY HEALTH INC - COM (TVTY) Institutional Ownership

Q: What is CUSIP 88870R102?

CUSIP 88870R102 is the security identifier used in SEC filing datasets for TVTY - TIVITY HEALTH INC - COM.

CUSIP: 88870R102

13F Institutional Holders and Ownership History from Q3 2016 to Q3 2022

Type / Class: Equity / COM
Symbol: TVTY

Reported Shares, Excluding Options vs Price

Reported Value, Excluding Options

Total Investors

Investment Quick Answers

What is CUSIP 88870R102?
CUSIP 88870R102 identifies TVTY - TIVITY HEALTH INC - COM in SEC 13F datasets.

Where can I see the latest institutional holders?
Use the ownership history tables below to review the newest available institutional filing periods.

Continue Investment Research

Latest 13F filings for new institutional portfolio disclosures.
Latest Schedule 13D/13G reports for activist and beneficial ownership updates.
Latest 10-Q/10-K reports to cross-check issuer fundamentals.
Recent insider transactions for management buying/selling context.
SEC investors directory and top value investors for manager-level discovery.
All institutional ownership pages to compare adjacent CUSIP pages.

Recent Quarterly Holder Reports

Open recent reporting periods for CUSIP 88870R102:

Q3 2022 (1 holder) Q2 2022 (4 holders) Q1 2022 (170 holders) Q4 2021 (159 holders) Q3 2021 (149 holders) Q2 2021 (155 holders) Q1 2021 (155 holders) Q4 2020 (152 holders) Q3 2020 (151 holders) Q2 2020 (132 holders)

Institutional Holders of TIVITY HEALTH INC - COM (TVTY) across Reporting Periods

Period	Reported Shares, Excl. Options	Value, Excl. Options	Value Change	Puts Notional Value	Calls Notional Value	Price (Median)	Investors
2022 Q3	22	$6,000	-$1,703,000			$272.73	1
2022 Q2	21,477	$703,000	-$1,418,746,667		$0	$32.84	4
2022 Q1	44,319,250	$1,425,350,760	-$38,392,452	$0	$1,194,000	$32.17	170
2021 Q4	45,602,353	$1,205,535,568	-$16,807,168	$212,000	$0	$26.44	159
2021 Q3	45,902,990	$1,059,046,637	+$41,490,492	$542,000	$2,518,000	$23.06	149
2021 Q2	44,066,861	$1,159,148,387	-$50,410,632	$1,584,000	$12,935,000	$26.31	155
2021 Q1	46,147,804	$1,030,514,118	+$673,150	$1,270,000	$11,178,000	$22.32	155
2020 Q4	46,220,788	$905,431,736	+$32,438,971	$889,000	$1,245,000	$19.59	152
2020 Q3	45,040,767	$631,384,981	-$36,059,044	$596,000	$834,000	$14.02	151
2020 Q2	47,551,295	$538,807,068	-$26,493,431	$5,606,000	$7,177,000	$11.33	132
2020 Q1	51,626,017	$324,757,586	-$113,190,945	$1,291,000	$21,746,000	$6.29	132
2019 Q4	54,166,914	$1,102,098,354	-$18,313,966	$3,922,000	$2,216,000	$20.34	167
2019 Q3	55,377,846	$920,879,840	-$42,228,069	$3,927,000	$1,270,000	$16.63	174
2019 Q2	58,002,653	$953,591,826	+$37,974,627	$5,130,000	$1,316,000	$16.44	193
2019 Q1	55,774,716	$979,508,605	+$173,461,417	$1,167,000	$11,000,000	$17.56	217
2018 Q4	44,610,248	$1,106,530,446	-$175,803,758	$2,143,000	$15,266,000	$24.81	210
2018 Q3	49,899,967	$1,604,303,618	+$13,506,824	$1,305,000	$14,523,000	$32.15	199
2018 Q2	48,836,906	$1,718,850,156	+$79,522,637	$1,144,000	$708,000	$35.20	201
2018 Q1	46,209,268	$1,827,602,634	+$12,342,703	$2,308,000	$3,969,000	$39.65	224
2017 Q4	46,115,207	$1,685,433,914	-$1,625,830	$1,927,000	$3,872,000	$36.55	215
2017 Q3	46,193,906	$1,887,895,004	+$95,956,026	$2,207,000	$1,448,000	$40.80	207
2017 Q2	43,878,865	$1,748,558,524	+$58,225,499	$1,077,000	$498,000	$39.85	186
2017 Q1	42,684,688	$1,242,117,836	+$1,142,918,187			$29.10	171
2016 Q4	3,394,856	$77,231,000	+$63,023,905			$22.75	12
2016 Q3	631,340	$16,803,000	+$16,524,000			$33.62	2